Senti Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Senti Biosciences Holdings

09/05/2023 23:10

* Senti Biosciences Inc  SNTI.OQ  reported a quarterly
adjusted
loss of 42 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 43 cents per share.
    * Revenue was $1.29 million​; analysts expected $466.67
thousand. 
    * Senti Biosciences Inc's reported EPS for the quarter was a
loss
of 42 cents​.
    * The mean earnings estimate of analysts had risen by
about 6.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Senti Biosciences Inc shares had fallen by 10.2% this
quarter and lost 24.8% so far this year.
    * The company reported a quarterly loss of $18.72 million.
    * Wall Street's median 12-month price target for Senti
Biosciences
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 10:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.43          -0.42          Beat
 Dec. 31 2022      -0.44          -0.42          Beat
 Sep. 30 2022      -0.46          -0.38          Beat